Last reviewed · How we verify
Application of crisaborole twice daily — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Application of crisaborole twice daily (Application of crisaborole twice daily) — Cairo University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Application of crisaborole twice daily TARGET | Application of crisaborole twice daily | Cairo University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Application of crisaborole twice daily CI watch — RSS
- Application of crisaborole twice daily CI watch — Atom
- Application of crisaborole twice daily CI watch — JSON
- Application of crisaborole twice daily alone — RSS
Cite this brief
Drug Landscape (2026). Application of crisaborole twice daily — Competitive Intelligence Brief. https://druglandscape.com/ci/application-of-crisaborole-twice-daily. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab